Further identification of the biomarkers that significantly correlated with the expression level of DEPP1 in the mPFC will benefit the diagnosis of possible comorbidity in depression and diabetes and will facilitate the research and development of an agent to achieve targeting effects. Here, DEPP1 is linked to depressive disorder.